Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study

Abstract

This is the first study to assess both direct and indirect costs in HS patients. HS imposes a substantial burden on patients and society, predominantly arising from productivity loss and biological therapy. Resource utilization data and cost-of-illness estimates provide valuable inputs into cost-effectiveness analyses of health interventions in HS.